Clinical Trial Update: The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.

View source ↗

Summary

A clinical trial update for the ITP-RITUX cohort examining rituximab in immune thrombocytopenia, sponsored by Henri Mondor University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Henri Mondor University Hospital | Conditions: Purpura, Thrombocytopenic, Idiopathic, Autoimmune Thrombocytopenia | Status: UNKNOWN